163 related articles for article (PubMed ID: 15201546)
21. [Local pulse pressure and regression of arterial wall hypertrophy during antihypertensive treatment. CELIMENE study. The Celiprolol Intima-Media Enalapril Efficacy study].
Boutouyrie P; Bussy C; Tropeano AI; Hayoz D; Hengstler J; Dartois N; Laloux B; Brunner H; Laurent S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):911-5. PubMed ID: 10989729
[TBL] [Abstract][Full Text] [Related]
22. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
23. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
[TBL] [Abstract][Full Text] [Related]
24. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B
Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
[TBL] [Abstract][Full Text] [Related]
25. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
Beltman F; Heesen W; Smit A; May J; de Graeff P; Havinga T; Schuurman F; van der Veur E; Lie K; Meyboom-de Jong B
J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
[TBL] [Abstract][Full Text] [Related]
26. Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes.
Koshiyama H; Tanaka S; Minamikawa J
J Cardiovasc Pharmacol; 1999 Jun; 33(6):894-6. PubMed ID: 10367592
[TBL] [Abstract][Full Text] [Related]
27. [Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint].
Ludwig M; von Petzinger-Kruthoff A; von Buquoy M; Stumpe KO
Ultraschall Med; 2003 Jun; 24(3):162-74. PubMed ID: 12817310
[TBL] [Abstract][Full Text] [Related]
28. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.
Zanchetti A; Crepaldi G; Bond MG; Gallus GV; Veglia F; Ventura A; Mancia G; Baggio G; Sampieri L; Rubba P; Collatina S; Serrotti E
J Hypertens; 2001 Jan; 19(1):79-88. PubMed ID: 11204308
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
[TBL] [Abstract][Full Text] [Related]
30. Carotid artery hemodynamics: observing patient-specific changes with amlodipine and lisinopril by using MR imaging computation fluid dynamics.
Ariff BB; Glor FP; Crowe L; Xu XY; Vennart W; Firmin DN; Thom SM; Hughes AD
Radiology; 2010 Dec; 257(3):662-9. PubMed ID: 20935080
[TBL] [Abstract][Full Text] [Related]
31. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
[TBL] [Abstract][Full Text] [Related]
32. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.
Stumpe KO; Agabiti-Rosei E; Zielinski T; Schremmer D; Scholze J; Laeis P; Schwandt P; Ludwig M;
Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):97-106. PubMed ID: 19124398
[TBL] [Abstract][Full Text] [Related]
33. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
Yilmaz R; Altun B; Kahraman S; Ozer N; Akinci D; Turgan C
Ren Fail; 2010; 32(8):903-12. PubMed ID: 20722555
[TBL] [Abstract][Full Text] [Related]
34. Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT.
Stumpe KO; Ludwig M; Heagerty AM; Kolloch RE; Mancia G; Safar M; Zanchetti A
Am J Cardiol; 1995 Nov; 76(15):50E-54E. PubMed ID: 7484890
[TBL] [Abstract][Full Text] [Related]
35. Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
Martinez-Martin FJ; Macias-Batista A; Comi-Diaz C; Rodriguez-Rosas H; Soriano-Perera P; Pedrianes-Martin P
Clin Drug Investig; 2011; 31(3):201-12. PubMed ID: 21155616
[TBL] [Abstract][Full Text] [Related]
36. Carotid and femoral B-mode ultrasound intima-media thickness measurements in adult post-coarctectomy patients.
Vriend JJ; De Groot E; Kastelein JJ; Mulder BJ
Int Angiol; 2004 Mar; 23(1):41-6. PubMed ID: 15156129
[TBL] [Abstract][Full Text] [Related]
37. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
38. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Leenen FH; Nwachuku CE; Black HR; Cushman WC; Davis BR; Simpson LM; Alderman MH; Atlas SA; Basile JN; Cuyjet AB; Dart R; Felicetta JV; Grimm RH; Haywood LJ; Jafri SZ; Proschan MA; Thadani U; Whelton PK; Wright JT;
Hypertension; 2006 Sep; 48(3):374-84. PubMed ID: 16864749
[TBL] [Abstract][Full Text] [Related]
39. Effect of blood pressure and physical activity on carotid artery intima-media thickness in stage 1 hypertensives and controls.
Casiglia E; Palatini P; Da Ros S; Pagliara V; Puato M; Dorigatti F; Pauletto P
Am J Hypertens; 2000 Dec; 13(12):1256-62. PubMed ID: 11130768
[TBL] [Abstract][Full Text] [Related]
40. Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Muntner P; Levitan EB; Lynch AI; Simpson LM; Whittle J; Davis BR; Kostis JB; Whelton PK; Oparil S
J Clin Hypertens (Greenwich); 2014 May; 16(5):323-30. PubMed ID: 24739073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
